January 18, 2025 - 11:52

President-elect Trump is set to implement a transformative pro-growth agenda that aims to reshape key sectors of the economy, including energy, technology, and cryptocurrency. His plans are expected to introduce significant changes in tax policies, which could incentivize investment and spur economic growth.
Many CEOs across various industries are expressing optimism about the potential for deregulation and tax cuts, which they believe will create a more favorable business environment. The energy sector, in particular, anticipates a revival, as Trump has indicated support for fossil fuels and a reduction in environmental regulations.
In the tech industry, leaders are hopeful that the new administration will foster innovation through tax incentives and reduced bureaucratic hurdles. Meanwhile, the cryptocurrency market is watching closely, as Trump’s policies could either bolster or hinder its growth depending on regulatory approaches.
As Trump prepares to take office, the business community is gearing up for a new era of economic policies that could redefine the landscape of American industry.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...